Acute Myeloid Leukemia Clinical Practice Guidelines in Oncology

The incidence of leukemia, along with its precursor, myelodysplasia, appears to be rising, particularly in the population over age 60. Recently an expanded panel of clinicians from the NCCN member institutions joined to update guidelines for the treatment of acute myeloid leukemia. Although there are some areas in which clinical trials have led to significant improvements in treatment, for the most part, recent trials have only served to highlight the continued need for innovative strategies to overcome this disease. These guidelines focus on outlining reasonable treatment options based on the information available.

For the most recent version of the guidelines, please visit

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 324 108 6
PDF Downloads 223 77 1
EPUB Downloads 0 0 0